[125I]5-iodo-6-nitroquipazine: a potent and selective ligand for the 5-hyfroxytryptamine uptake complex. I. In vitro studies
- 1 August 1993
- journal article
- Published by Elsevier in Brain Research
- Vol. 619 (1-2) , 229-235
- https://doi.org/10.1016/0006-8993(93)91616-z
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- [125I]5-iodo-6-nitroquipazine: a potent and selective ligand for the 5-hydroxytrrptamine uptake complex. II. In vivo studies in ratsBrain Research, 1993
- Iodinated tomoxetine derivatives as selective ligands for serotonin and norepinephrine uptake sitesJournal of Medicinal Chemistry, 1992
- Synthesis and resolution of (.+-.)-7-chloro-8-hydroxy-1-(3'-iodophenyl)-3-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine (TISCH): a high affinity and selective iodinated ligand for CNS D1 dopamine receptorJournal of Medicinal Chemistry, 1991
- High affinity binding of [3H]6-nitroquipazine to cortical membranes in the rat: Inhibition by 5-hydroxytryptamine and 5-hydroxytryptamine uptake inhibitorsNeuropharmacology, 1991
- Reduction of [3H]6‐nitroquipazine‐labelled 5‐hydroxytryptamine uptake sites in rat brain by 3,4‐methylenedioxymethamphetamineFundamental & Clinical Pharmacology, 1990
- High-affinity [3H]6-nitroquipazine binding sites in rat brainEuropean Journal of Pharmacology, 1990
- Characterization of [3H]paroxetine binding to rat cortical membranesEuropean Journal of Pharmacology, 1985
- Quantitative Autoradiography of [3H]Indalpine Binding Sites in the Rat Brain: I. Pharmacological CharacterizationJournal of Neurochemistry, 1985
- Distribution of imipramine binding sites in the rat brain studied by quantitative autoradiographyNeuroscience Letters, 1983
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973